EUCTR2011-001033-16-GB进行中（未招募）1 期
Safety and Efficacy of NNC 0155-0000-0004 inPrevention and Treatment of Bleeds in PaediatricPreviously Untreated Patients with Haemophilia A - guardian™4
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •- Informed consent obtained before any trial-related activities (trial-related activities are any procedure that would not have been performed during normal management of the patient)
- •- Male patients with congenital severe haemophilia A (baseline level FVIII <=1%)
- •- Age < 6 years
- •- No prior use of purified clotting factor products (previous exposure to blood components is acceptable)
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 120
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Known or suspected allergy to hamster protein or intolerance to trial product(s) or related products
- •- Previous participation in this trial defined as withdrawal after administration of trial product
- •- Congenital or acquired coagulation disorders other than haemophilia A
- •- FVIII inhibitor (>= 0.6 BU/mL) at screening
- •- Ongoing treatment or planned treatment during the trial with immunomodulatory agents (e.g. intravenous immunoglobulin (IVIG)), routine systemic corticosteroids)
- •- Platelet count <50,000 platelets/µL
研究者
相似试验
进行中（未招募）
1 期
Safety and efficacy of NNC 0155-0000-0004 inprevention and treatment of bleeds in previously untreated children with Haemophilia AHaemophilia AMedDRA version: 14.1Level: LLTClassification code 10018937Term: Haemophilia ASystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-001033-16-ESovo Nordisk A/S60
进行中（未招募）
1 期
Safety and efficacy of NNC 0155-0000-0004 in prevention and treatment of bleeds in previously untreated children with Haemophilia AHaemophilia AMedDRA version: 14.1 Level: LLT Classification code 10018937 Term: Haemophilia A System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-001033-16-GRovo Nordisk A/S60
进行中（未招募）
1 期
Research study on whether a combination of 2 medicines (NNC0194-0499 and semaglutide) works in people with non-alcoholic steatohepatitis (NASH)EUCTR2020-003566-39-BGovo Nordisk A/S672
进行中（未招募）
2 期
Research study on whether a combination of 2 medicines (NNC0194-0499 and semaglutide) works in people with non-alcoholic steatohepatitis (NASH)CTRI/2021/10/037678ovo Nordisk AS
进行中（未招募）
1 期
Research study on whether a combination of 2 medicines (NNC0194-0499 and semaglutide) works in people with non-alcoholic steatohepatitis (NASH)on-alcoholic steatohepatitisMedDRA version: 24.1Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2020-003566-39-GRovo Nordisk A/S672